AmerisourceBergen, #8 on the Fortune 500, sets aside $150 million for its first corporate venture fund
It was March 2020—right before the pandemic exploded—when AmerisourceBergen’s executive team first pitched the idea to the healthcare solution company’s board of directors. Their sell: It was time for AmerisourceBergen to take a more hands-on approach to working with entrepreneurs and pharmaceutical testing. The company, which is one of the top pharmaceutical distributors in the world and posted nearly $214 billion in revenue in the year ending in Sep. 2021, had previously made an occasional investment here and there. Now it wanted to parse through hundreds of investment opportunities a year and develop better insights into the market, says Leslie Donato, AmerisourceBergen’s executive vice president and Chief Strategy Officer.
For the full article, please visit Fortune.